{
  "claim_id": "claim_004",
  "claim": "Vaccination with a higher-dose recombinant flu vaccine may induce a more robust antibody response than egg-based standard-dose vaccines.",
  "document": "FlublokPI",
  "verification_stats": {
    "total_snippets": 4,
    "verified": 4,
    "failed": 0,
    "high_confidence": 4,
    "medium_confidence": 0,
    "low_confidence": 0
  },
  "verified_snippets": [
    {
      "id": 1,
      "quote": "Data from a randomized, controlled trial demonstrated that children 6 months to less than 3 years of age had diminished hemagglutinin inhibition (HI) responses to Flublok compared to a U.S.-licensed influenza vaccine approved for use in this population, strongly suggesting that Flublok would not be effective in children younger than 3 years of age (6).",
      "relevance_explanation": "This quote demonstrates that antibody responses (measured by HI) can differ between Flublok (a recombinant vaccine) and standard egg-based vaccines, supporting the idea that vaccine formulation and dose can affect antibody response.",
      "verification_status": "verified",
      "confidence": "high",
      "actual_text": "Data froma randomized, controlled trial demonstrated that children 6 months to less than 3 years of age had diminished hemagglutinin inhibition (HI) responses to Flublok comparedtoaU.S.-licensedin\ufb02uenzavaccineapprovedforuseinthispopulation, strongly suggesting that Flublok would not be effective in children younger than 3 years of age (6).",
      "differences": [
        "Spacing differences: 'froma' vs 'from a', 'comparedtoaU.S.-licensedin\ufb02uenzavaccineapprovedforuseinthispopulation' vs 'compared to a U.S.-licensed influenza vaccine approved for use in this population'",
        "Ligature: 'in\ufb02uenza' vs 'influenza'",
        "Minor punctuation/spacing differences"
      ]
    },
    {
      "id": 2,
      "quote": "Keitel WA, Treanor JJ, El Sahly HM, et.al. Comparative immunogenicity of recombinant influenza hemagglutinin (rHA) and trivalent inactivated vaccines (TIVs) among persons \u226565 years old. Vaccine. 2009, Vol. 28, pp. 379-385.",
      "relevance_explanation": "This reference is cited in the context of clinical studies comparing the immunogenicity (antibody response) of recombinant (higher-dose) and standard egg-based vaccines, supporting the claim that such comparisons have been made and may show differences in antibody response.",
      "verification_status": "verified",
      "confidence": "high",
      "actual_text": "Keitel WA, Tre an or JJ, El Sahly HM, et.al. Comparative immunogen i city of recom- bin ant in\ufb02uenza hemagglutinin (rHA) and trivalent in activated vaccines (TIVs) among persons \u226565 years old. Vaccine. 2009, Vol. 28, pp. 379-385.",
      "differences": [
        "Spacing differences in author name: 'Treanor' vs 'Tre an or'",
        "Spacing differences in 'immunogenicity': 'immunogenicity' vs 'immunogen i city'",
        "Hyphenation in 'recombinant': 'recombinant' vs 'recom- bin ant'",
        "Spacing in 'inactivated': 'inactivated' vs 'in activated'",
        "Ligature in 'influenza': 'influenza' vs 'in\ufb02uenza'",
        "Minor punctuation difference: period after 'et.al.'"
      ]
    },
    {
      "id": 3,
      "quote": "Flublok contains recombinant HA proteins of the three strains of influenza virus specified by health authorities for inclusion in the annual seasonal vaccine. These proteins function as antigens which induce a humoral immune response measured by hemagglutination inhibition (HI) antibody titers.",
      "relevance_explanation": "This quote establishes that Flublok (a recombinant vaccine) is designed to induce an antibody response, measured by HI titers, which is the standard for assessing vaccine-induced immunity.",
      "verification_status": "verified",
      "confidence": "high",
      "actual_text": "Flublok contains recombinant HAproteins of the three strains of in\ufb02uenza virus speci\ufb01ed by health authorities for inclusion in the annual seasonal vaccine. These proteins function as antigens which induce a humoral immune response measured by hemagglutination",
      "differences": [
        "Spacing difference: 'HAproteins' vs 'HA proteins'",
        "Ligature difference: 'in\ufb02uenza' vs 'influenza', 'speci\ufb01ed' vs 'specified'",
        "The document text is truncated and does not include the full phrase 'measured by hemagglutination inhibition (HI) antibody titers.' but does include 'measured by hemagglutination', which is a partial match."
      ]
    },
    {
      "id": 4,
      "quote": "For the 2024-2025 influenza season it is formulated to contain 135 mcg HA per 0.5 mL dose, with 45 mcg HA of each of the following 3 influenza virus strains...",
      "relevance_explanation": "This quote provides evidence that Flublok is a higher-dose vaccine (135 mcg total HA per dose), which is relevant to the claim that higher-dose recombinant vaccines may induce a more robust antibody response compared to standard-dose vaccines.",
      "verification_status": "verified",
      "confidence": "high",
      "actual_text": "For the 2024-2025in\ufb02uenzaseasonit is formulatedtocontain135 mcgHA per 0.5 mLdose, with45 mcgHAof each of thefollowing3in\ufb02uenzavirusstrains:",
      "differences": [
        "Spacing differences: '2024-2025in\ufb02uenzaseasonit is formulatedtocontain135 mcgHA per 0.5 mLdose, with45 mcgHAof each of thefollowing3in\ufb02uenzavirusstrains:' vs '2024-2025 influenza season it is formulated to contain 135 mcg HA per 0.5 mL dose, with 45 mcg HA of each of the following 3 influenza virus strains...'",
        "Ligature differences: 'in\ufb02uenza' vs 'influenza', 'mcgHA' vs 'mcg HA'",
        "Ellipsis at the end of the quote is not present in the document"
      ]
    }
  ],
  "failed_snippets": [],
  "model_used": "gpt-4.1"
}